Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 1, 2007, Pages 29-37

  D'Alessandro, Cosimo ^a   Leprince, Pascal ^a   Golmard, Jean Louis ^a   Ouattara, Alexandre ^a   Aubert, Stéphane ^a   Pavie, Alain ^a   Gandjbakhch, Iradj ^a   Bonnet, Nicolas ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRAL INSULIN;

AGED; ALGORITHM; ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SURGICAL RISK;

AGED; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; MALE; MONITORING, INTRAOPERATIVE; MYOCARDIAL REVASCULARIZATION; PERIOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 34250879666     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.02.028     Document Type: Article

References (34)

1. Bonow R.O., and Gheorghiade M. The diabetes epidemic: a national and global crisis. Am J Med. 116 suppl 5A (2004) 2S-10S
2. Kannel W.B., and McGee D.L. Diabetes and cardiovascular risk: the Framingham study. JAMA 241 (1979) 2035-2038
3. Flaherty J.D., and Davidson J.C. Diabetes and coronary revascularization. JAMA 293 (2005) 1501-1508
4. Edwards F.H., Grower F.L., Shroyer A.L., Schwartz M., and Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 63 (1997) 903-908
5. Calafiore A.M., Di Mauro M., Di Giammarco G., Contini M., Vitolla G., Iaco A.L., et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg. 125 (2003) 144-154
6. Thourani V.H., Weintraub W.S., Stein B., Gebhart S.S.P., Craver M.J., Jones E.L., et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 67 (1999) 1045-1052
7. Barsness G.W., Peterson E.D., Ohmam E.M., Nelson C.L., DeLong E.R., Reves J.G., et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96 (1997) 2551-2556
8. Malmberg K., Ryden L., Hamsten A., Efendic S., Herlitz J., Nicol P., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 26 (1995) 57-65
9. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 125 (2003) 1007-1021
10. Lazar H.L., Chipkin S.R., Fitzgerald C.A., Bao Y., Cabtal H., and Apstein C.S. Tight glycemic control in diabetic coronary bypass graft patients improves perioperative outcomes and decreases recurrent ischemic event. Circulation 109 (2004) 1497-1502
11. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 345 (2001) 1359-1367
12. Ouattara A., Lecomte P., Le Manach Y., Landi M., Jacqueminet S., Platonov I., et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103 (2005) 687-694
13. Nashef S.A.M., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R., et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 16 (1999) 9-13
14. D'Agostino Jr. R.B. Tutorial in biostatistics: propensity score methods for bas reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 17 (1998) 2265-2281
15. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg. 123 (2002) 8-15
16. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Heller C.A. Hyperglycemia: a predictor of mortality following CABG in diabetics. Circulation 100 suppl (1999) I591
17. Doenst T., Wijeysundera D., Karkouti K., Zechner C., Maganti M., Rao V., et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 130 (2005) 1144-1150
18. Chaney M.A., Nikolov M.P., Blakerman B.P., and Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg. 99 (1999) 1091-1095
19. Carvalho G., Moore A., Qizilbash B., Lachapelle K., and Schricker T. Maintenance of normoglycemia during open cardiac surgery. Anesth Analg. 99 (2004) 319-324
20. Schricker T., and Carvalho G. Pro: tight perioperative glycemic control. J Cardiothorac Vasc Anesth. 19 (2005) 684-688
21. Gogbashian A., Sedrakyan A., and Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg. 25 (2004) 695-700
22. Nilsson J., Algotsson L., Höglund P., Lührs C., and Brandt J. Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg. 77 (2004) 1235-1239
23. Toumpoulis I.K., Anagnostopoulos C.E., Toupoulis S.K., DeRose J.J., and Swistel D.G. EuroSCORE predicts long-term mortality after valve surgery. Ann Thorac Surg. 79 (2005) 1902-1908
24. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J. 24 (2003) 881-882
25. Michel P., Roques F., Nashef S.A., and The EuroSCORE Project Group. Logistic or additive EuroSCORE for high-risk patients?. Eur J Cardiothorac Surg. 23 (2003) 684-687
26. Shanmungam G., West M., and Berg G. Additive and logistic EuroSCORE performance in high risk patients. Interact Cardio Vasc Thorac Surg. 28 (2005) 240-243
27. Jin R., and Grunkemeier G.L. Does the logistic EuroSCORE offer an advantage over the additive model?. Interact Cardio Vasc Thorac Surg. 5 (2006) 15-17
28. Peterson E.D., Delong E.R., Muhlbaier L.H., Rosen A.B., Buell H.E., Kiefe C.I., et al. Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 36 (2000) 2174-2184
29. Lytle B.W., Blackstone E.H., Loop F.D., Houghtaling P.L., Arnold J.H., Akhrass R., et al. Two internal thoracic artery are better than one. J Thorac Cardiovasc Surg. 117 (1999) 855-872
30. Peterson M.D., Borger M.A., Rao V., Peniston C.M., and Feindel C.M. Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg. 1236 (2003) 1314-1319
31. Zerr K.J., Furnary A.P., Grunkemeier G., Bookin S., Kanhere V., and Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 63 (1997) 356-361
32. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 67 (1999) 352-360
33. Borger M.A., Rao V., Weisel R.D., Ivanov J., Cohen G., Scully H.E., et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg. 65 (1998) 1050-1056
34. Wilson S.R., Vakili B.A., Sherman W., Sanborn T.A., and Brown D.L. Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention. Diabetes Care 27 (2004) 1137-1142